Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas

Thomas W. Kensler, Patricia A. Egner, Jin Bing Wang, Yuan Rong Zhu, Bao Chu Zhang, Pei Xin Lu, Jian Guo Chen, Geng Sun Qian, Shuang Yuan Kuang, Peta E. Jackson, Stephen J. Gange, Lisa P. Jacobson, Alvaro Muñoz, John D. Groopman

Research output: Contribution to journalArticlepeer-review

124 Scopus citations


Hepatocellular carcinoma is one of the most common cancers worldwide. Infection with hepatitis B virus and exposure to aflatoxins in the diet act synergistically to amplify risk. From a public health perspective, hepatitis virus vaccination programs and efforts to both reduce aflatoxin exposures and to attenuate the toxicological consequences of unavoidable exposures should have major impacts on the global incidence of this disease. Experimentally, aflatoxin-induced hepatocarcinogenesis can be inhibited by over a score of different chemopreventive agents with multiple mechanisms of action. One agent, oltipraz, is a potent inducer of phase 2 enzymes involved in the detoxication of carcinogens including aflatoxin. A second agent, chlorophyllin, impedes the bioavailability of carcinogens by forming molecular complexes and enhances their elimination in the fecal stream. This review highlights the findings of recent randomized clinical trials with oltipraz and chlorophyllin conducted in individuals exposed to dietary aflatoxins and at high risk for development of liver cancer. Both chemopreventive agents modulated levels of aflatoxin biomarkers in the study participants in manners consonant with protection. Although pharmacological approaches establish proof of principle and help identify key molecular targets for interventions, food-based approaches that also use these molecular targets may be the most practical for widespread application in high-risk populations.

Original languageEnglish (US)
Pages (from-to)S310-S318
Issue number5 SUPPL.
StatePublished - Nov 2004

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas'. Together they form a unique fingerprint.

Cite this